Header Logo

Connection

WEN-JEN HWU to Drug Therapy, Combination

Back to Details
This is a "connection" page, showing publications WEN-JEN HWU has written about Drug Therapy, Combination.
WEN-JEN HWU
Connection Strength
0.085
Drug Therapy, Combination
  1. Treatment of metastatic melanoma in the brain with temozolomide and thalidomide. Lancet Oncol. 2001 Oct; 2(10):634-5.
    View in: PubMed
    Score: 0.034
  2. Molecular basis for thymidine modulation of the efficacy and toxicity of alkylating agents. Pharmacol Ther. 1997 Oct-Dec; 76(1-3):101-16.
    View in: PubMed
    Score: 0.026
  3. Standard-dose pembrolizumab in combination with reduced-dose ipilimumab for patients with advanced melanoma (KEYNOTE-029): an open-label, phase 1b trial. Lancet Oncol. 2017 09; 18(9):1202-1210.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.